Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Differing fasting glucose levels may reveal more information than just sugar level and how well it is managed.
Read More »Fasting Glucose Variation Predicts Microvascular Risk
PK/PD of Glargine-300units/ml Compared to Degludec-100units/ml
Glargine and degludec had similar glycemic control with some differences in pharmacokinetics (PK) and pharmacodynamics (PD).
Read More »Cause-Specific Mortality Due to Hypoglycemia
A retrospective observational study seeks to determine absolute risk of death due to CVD, cancer, and other causes in patients who experienced a severe hypoglycemic event.
Read More »The Role of Dapagliflozin in Patients with Type 2 Diabetes and Atrial Fibrillation
A post hoc analysis of the DECLARE-TIMI 58 trial may provide a new compelling indication for dapagliflozin.
Read More »Glycemic Benefit of Weekly GLP-1 Agonist: Albiglutide
Simple add-on therapy can reduce insulin use for patients with type 2 diabetes.
Read More »How Patients with T2DM Can Safely Consume Food with High Glycemic Index
A new study shows that a potato-based diet does not disturb blood sugar control in patients with type 2 diabetes mellitus (T2DM).
Read More »The Impact of Intensity Variation in Physical Activity on Mortality Rates
Does a higher percentage of vigorous physical activity as part of total exercise time confer additional benefits?
Read More »DNA Does Not Forget
Because of metabolic memory, complications of poor glucose control may not be reversed and will continue to progress even after glucose levels are normalized.
Read More »Risk of Anemia with Metformin Use in Patients with Type 2 Diabetes
Metformin use can reduce protein hemoglobin levels that carry oxygen in the blood.
Read More »Dipeptidyl Peptidase-4 Role in Patients with Renal Transplant
Diabetes management can be a major factor in renal transplant aftercare; can DPP-4 therapy help improve outcomes?
Read More »